C. J. Hu

Molecular Biology · 2010–2015

A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom C. J. Hu trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Huan Meng
  2. Michael M. Gottesman
  3. M. Liong
  4. Mark E. Davis

Papers from C. J. Hu's perspective

Ordered by how strongly the researchers C. J. Hu trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Mechanisms of cancer drug resistance. (Annual Review of Medicine)
  2. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. (Small)
  3. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. (Biochemical Journal)
  4. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers (Proceedings of the National Academy of Sciences of the United States of America)
  5. Nanoparticles in Medicine: Therapeutic Applications and Developments (Clinical pharmacology and therapy)
  6. Role of CD47 as a marker of self on red blood cells. (Science)
  7. Nanoparticle therapeutics: an emerging treatment modality for cancer (Nature reviews. Drug discovery)
  8. The emerging nanomedicine landscape (Nature Biotechnology)
  9. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. (Nature Nanotechnology)
  10. Interfering with disease: a progress report on siRNA-based therapeutics (Nature reviews. Drug discovery)

Their papers